Gynecomastia Procedures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Age Group (18-40, Above 40), By Procedure Type (Liposuction, Excision), By End-Use (Hospitals, Cosmetic Surgery Center), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 0.18 Billion
CAGR (2026-2031)	8.54%
Fastest Growing Segment	Above 40 years
Largest Market	North America
Market Size (2031)	USD 0.29 Billion

Market Overview

The Global Gynecomastia Procedures Market will grow from USD 0.18 Billion in 2025 to USD 0.29 Billion by 2031 at a 8.54% CAGR. Gynecomastia procedures involve the surgical reduction of overdeveloped glandular or fatty breast tissue in men to restore a flatter and more masculine chest contour. The primary drivers fueling market growth include increased societal acceptance of male aesthetic treatments and a heightened focus on physical appearance and mental well-being. Furthermore, the rising incidence of hormonal imbalances resulting from medication use and lifestyle factors continues to generate consistent demand for corrective interventions.

According to the International Society of Aesthetic Plastic Surgery, in 2023, a total of 352,302 gynecomastia procedures were performed worldwide. Despite this activity, the market faces a significant challenge concerning insurance reimbursement policies. Most healthcare providers classify this surgery as a cosmetic enhancement rather than a medical necessity, resulting in high out-of-pocket expenses that restrict patient access and dampen overall market expansion.

Key Market Drivers

The heightened influence of social media and celebrity culture on male beauty standards is a primary force propelling the global gynecomastia procedures market. Men are increasingly exposed to digital content that idealizes a sculpted, "V-taper" physique, leading to greater scrutiny of their own chest contours and a growing desire for surgical correction of overdeveloped tissue. This shift in societal perception has destigmatized male cosmetic interventions, encouraging a larger demographic to seek professional treatment for aesthetic rather than purely medical reasons. Consequently, procedure volumes have remained robust at the national level, driven by this persistent demand for masculine chest definition. According to The Aesthetic Society, June 2024, in the '2023 Aesthetic Plastic Surgery Statistics', gynecomastia treatment solidified its position as the second most popular surgical procedure for men in the United States, with 21,043 operations performed.

Simultaneously, rising disposable income and the willingness to incur significant expenditure on elective medical treatments are sustaining market value. Since most insurance policies categorize male breast reduction as a cosmetic enhancement, patients must often bear the full financial burden, yet the market continues to thrive despite these economic barriers. This trend is evident in the escalating costs associated with the surgery, which reflect both inflationary pressures and the premium value consumers place on specialized aesthetic outcomes. According to the American Society of Plastic Surgeons, June 2024, in the '2023 Plastic Surgery Statistics Report', the average surgeon fee for male breast reduction rose to $5,587. This willingness to invest in aesthetic improvement aligns with broader industry resilience, as The Aesthetic Society reported in 2024 that the total volume of surgical procedures increased by 2.9 percent year-over-year.

Download Free Sample Report

Key Market Challenges

The classification of gynecomastia surgery as a cosmetic enhancement by the majority of insurance providers constitutes a substantial barrier to the growth of the global market. Because healthcare payers frequently categorize this procedure as non-medically necessary, applications for coverage are routinely denied, compelling patients to shoulder the entire financial burden. This liability extends beyond the surgeon's fee to include facility costs and anesthesia expenses, creating a high economic threshold that effectively prices out a significant portion of the addressable population who suffer from the condition but lack the disposable income for elective surgery.

Consequently, this reimbursement landscape directly suppresses the conversion of high patient interest into actual surgical volume. Despite the rising incidence of the condition and improved social acceptance, the market struggles to achieve rapid expansion as the financial prohibitive factors limit accessibility. According to the American Society of Plastic Surgeons, in 2024, the volume of gynecomastia reduction procedures increased by only 2%. This marginal growth rate serves as a clear indicator that the lack of insurance support is actively dampening market momentum and preventing the industry from fully capitalizing on the underlying demand.

Key Market Trends

The transition of surgical volumes from traditional hospitals to specialized ambulatory centers is fundamentally reshaping the operational landscape of the gynecomastia market. This structural shift is largely driven by the demand for enhanced patient privacy and operational efficiency, which are critical factors for the male demographic seeking discretion. Specialized facilities offer a streamlined pathway that circumvents the administrative complexities and higher overhead costs associated with general hospitals, thereby making the procedure more accessible while maintaining high safety standards. The preference for these dedicated environments is evident in recent facility utilization data. According to The Aesthetic Society, July 2024, in the '2023 Aesthetic Plastic Surgery Statistics', 64% of all cosmetic surgical procedures were performed in Accredited Surgical Centers, contrasting sharply with the limited volume retained by hospital settings.

Concurrently, the dominance of energy-assisted liposuction technologies over traditional excision represents a pivotal clinical shift in treatment protocols. Surgeons are increasingly adopting advanced modalities, such as radiofrequency-assisted or power-assisted lipolysis, to address glandular tissue and fat with superior precision and minimal scarring. Unlike conventional scalpel-based techniques, these energy-based systems facilitate simultaneous fat removal and skin retraction, offering a "shrink-wrapping" effect that is highly sought after by patients desiring a sculpted chest without the stigma of large surgical scars. This technological adoption is reflected in the growing patient throughput for specialized body contouring providers. According to AirSculpt Technologies, February 2024, in the 'Fourth Quarter and Full Year 2023 Financial Results', the company reported that its case volume, driven by proprietary energy-based body contouring techniques, increased by 14.3% year-over-year.

Segmental Insights

The Above 40 years segment represents the fastest-growing category in the Global Gynecomastia Procedures Market, driven by a convergence of physiological and socioeconomic factors. Research indicates that the natural decline in testosterone levels associated with aging, coupled with rising obesity rates in this demographic, significantly increases the incidence of glandular enlargement. Additionally, the prevalence of age-related conditions requiring medications that list gynecomastia as a side effect further elevates procedural demand. This trend is bolstered by the higher disposable income among older adults, enabling them to invest in aesthetic surgeries to address these physical changes.

Regional Insights

North America leads the global gynecomastia procedures market, primarily driven by the high volume of cosmetic interventions and rising patient awareness regarding physical appearance. Data from the American Society of Plastic Surgeons indicates a consistent demand for male breast reduction surgeries within the United States, solidifying the region's market standing. This dominance is supported by a well-developed healthcare sector and widespread access to specialized surgical care. Furthermore, the growing willingness of the male population to invest in aesthetic enhancements drives the continuous expansion of the market in this region, ensuring its sustained leadership.

Recent Developments

• In May 2025, Apyx Medical Corporation received 510(k) clearance from the U.S. Food and Drug Administration for its AYON Body Contouring System. This breakthrough all-in-one platform integrates the company’s proprietary Renuvion helium plasma technology with ultrasound-assisted liposuction and electrocoagulation capabilities. Designed to address the needs of surgeons performing procedures like male breast reduction, the system facilitates simultaneous fat removal and skin tightening. The company announced plans to commence a commercial launch in the second half of the year, stating that the system’s "LIFT Technology" allows for real-time adjustments to maximize surgical precision and patient results.
• In July 2024, InMode Ltd. announced the launch of the IgniteRF platform, a comprehensive minimally invasive workstation designed to advance soft tissue contraction and body remodeling. This new system incorporates several proprietary technologies, including the BodyTite Turbo and FaceTite Turbo handpieces, which are instrumental in procedures such as gynecomastia correction and fat reduction. The company highlighted that the platform allows surgeons to treat various tissue depths with greater precision and efficiency. By combining multiple radiofrequency modalities into a single station, InMode aims to improve clinical outcomes and streamline workflow for aesthetic providers performing body contouring surgeries.
• In April 2024, Hahn & Company successfully completed the strategic merger of Cynosure and Lutronic, uniting two leading global manufacturers of energy-based medical aesthetic devices. The newly formed entity, Cynosure Lutronic, Inc., aims to leverage the combined expertise and extensive resources of both companies to drive innovation in the aesthetics industry. This collaboration integrates their diverse product portfolios, including advanced laser and radiofrequency systems used for body contouring and skin revitalization, to provide comprehensive solutions for practitioners. The organization stated that this union positions them to better serve customers globally through enhanced research and development capabilities.
• In March 2024, the Cleveland Clinic Abu Dhabi unveiled a novel reconstructive surgical technique designed to significantly enhance aesthetic outcomes for patients undergoing gynecomastia treatment. This innovative procedure utilizes the thickened and anomalous inframammary fold often present under enlarged male breasts to augment the pectoralis muscle, effectively preventing the "dished-out" or concave chest appearance that can result from traditional tissue removal. Medical experts at the organization emphasized that this technique addresses common post-surgical deformities, offering patients improved body contouring results and higher satisfaction with their physical appearance following the corrective surgery.

Key Market Players

• Allergan Aesthetics
• Sientra
• Cynosure
• Cutera
• Galderma
• Heraeus
• Clarion Medical
• Mazor Robotics
• InMode

By Age Group	By Procedure Type	By End-Use	By Region
18-40 Above 40	Liposuction Excision	Hospitals Cosmetic Surgery Center	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Gynecomastia Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Gynecomastia Procedures Market, By Age Group:

• 18-40
• Above 40

• Gynecomastia Procedures Market, By Procedure Type:

• Liposuction
• Excision

• Gynecomastia Procedures Market, By End-Use:

• Hospitals
• Cosmetic Surgery Center

• Gynecomastia Procedures Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE